The Thread Formerly Known as No Rest For The Wicked Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Captain Ed who wrote (2895)	12/10/1998 9:28:00 PM
From: HandsOn	Read Replies (1) of 90042

I'll watch GERN, CTII is way ahead of GERN re clinical application with Stem Cells. CTII is trading below it's book value, and has gotten 4 patents recently. It had an article in Nov. 24th issue of Business Week about how far ahead They are compared to GERN. When They get some exposure CTII will really pop. Tim looking for a nice move on GLGC Tomorrow, thanks again.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next